EDGAR Filing Documents for 0001213900-22-031258

Form 8-K - Current report:

SEC Accession No. 0001213900-22-031258

Filing Date

2022-06-06

Accepted

2022-06-03 21:51:07

Documents

Period of Report

2022-06-01

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea161175-8k_inmedphar.htm iXBRL	8-K	44365
2	FORM OF PREFERRED INVESTMENT OPTION	ea161175ex4-1_inmedphar.htm	EX-4.1	104104
3	FORM OF PRE-FUNDED WARRANT	ea161175ex4-2_inmedphar.htm	EX-4.2	96988
4	FORM OF PRE-FUNDED WARRANT	ea161175ex4-3_inmedphar.htm	EX-4.3	92506
5	WARRANT AMENDMENT AGREEMENT	ea161175ex4-4_inmedphar.htm	EX-4.4	8032
6	FORM OF SECURITIES PURCHASE AGREEMENT	ea161175ex10-1_inmedphar.htm	EX-10.1	230156
7	FORM OF SECURITIES PURCHASE AGREEMENT	ea161175ex10-2_inmedphar.htm	EX-10.2	220830
8	REGISTRATION RIGHTS AGREEMENT	ea161175ex10-3_inmedphar.htm	EX-10.3	165325
9	PRESS RELEASE, DATED JUNE 2, 2022	ea161175ex99-1_inmedphar.htm	EX-99.1	15474
10	GRAPHIC	ex99-1_001.jpg	GRAPHIC	5094
	Complete submission text file	0001213900-22-031258.txt		1401097

Data Files

Seq	Description	Document	Type	Size
11	XBRL SCHEMA FILE	inm-20220601.xsd	EX-101.SCH	3039
12	XBRL LABEL FILE	inm-20220601_lab.xml	EX-101.LAB	34476
13	XBRL PRESENTATION FILE	inm-20220601_pre.xml	EX-101.PRE	22600
15	EXTRACTED XBRL INSTANCE DOCUMENT	ea161175-8k_inmedphar_htm.xml	XML	3617

Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4

Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207

InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)